Skip to main content
SpringerLink
Log in

Multiple Sclerosis, Gender, and Disorders of Behavior

  • Chapter
  • First Online:
Health Issues in Women with Multiple Sclerosis

  • 598 Accesses

Abstract

Multiple sclerosis (MS) is associated with a wide array of behavioral disorders that may be grouped into two broad categories, namely, those affecting cognition on the one hand and mood and affect on the other. Very little research has been specifically devoted to how gender may impact these conditions. When gender is discussed, it is largely in passing, as just one more variable in a lengthy list of factors that may, or may not, be associated with a particular disorder that is the focus of the researchers’ attention. The fact that gender has been largely bypassed in this fashion, however, should not obscure its potential importance, primarily as a modifier of psychopathology and cognition. This chapter will therefore provide an overview of disorders of cognition, mood, and affect in people with MS and, where relevant, highlight their associations with gender.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO. Gender disparities in mental health world. Ment Heal Minist Round Tables 54th World Heal Assem. 2001;48(5):1–25.

    Google Scholar 

  2. Feinstein A. Multiple sclerosis and depression. Mult Scler. 2011;17(11):1276–81.

    Article  PubMed  Google Scholar 

  3. Patten S, Beck C, Williams J, Barbui C, Metz L. Major depression in multiple sclerosis: a population-based perspective. Neurology. 2003;61(11):1524–7.

    Article  CAS  PubMed  Google Scholar 

  4. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article  CAS  PubMed  Google Scholar 

  5. Amato M, Ponziani G, Rossi F, Liedl C, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001;7(5):340–4.

    Article  CAS  PubMed  Google Scholar 

  6. Arnett P, Higginson C, Voss W, Bender W, Wurst J, Tippin J. Depression in multiple sclerosis: relationship to working memory capacity. Neuropsychology. 1999;13(4):546–56.

    Article  CAS  PubMed  Google Scholar 

  7. Stenager EN, Stenager E, Koch-Henriksen N, Brønnum-Hansen H, Hyllested K, Jensen K, et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry. 1992;55(7):542–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Feinstein A, Roy P, Lobaugh N, Feinstein K, O’Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology. 2004;62(4):586–90.

    Article  CAS  PubMed  Google Scholar 

  9. Akbar N, Lobaugh NJ, O’Connor P, Moradzadeh L, Scott CJM, Feinstein A. Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients. Can J Neurol Sci. 2010;37(5):608–14.

    Article  PubMed  Google Scholar 

  10. Lynch SG, Kroencke DC, Denney DR. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Mult Scler. 2001;7(6):411–6.

    Article  CAS  PubMed  Google Scholar 

  11. Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB, et al. Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(2):174–81.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J. Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev. 2011;(2):CD007295.

    Google Scholar 

  13. Dahl O-P, Stordal E, Lydersen S, Midgard R. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway. Mult Scler. 2009;15(12):1495–501.

    Article  PubMed  Google Scholar 

  14. Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol. 2008;15(3):239–45.

    Article  CAS  PubMed  Google Scholar 

  15. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002;159(11):1862–8.

    Article  PubMed  Google Scholar 

  16. Galeazzi GM, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, et al. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci. 2005;26(4):255–62.

    Article  CAS  PubMed  Google Scholar 

  17. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol. 2001;248(5):416–21.

    Article  CAS  PubMed  Google Scholar 

  18. Montel SR, Bungener C. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis. Mult Scler. 2007;13(3):393–401.

    Article  CAS  PubMed  Google Scholar 

  19. D’Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil. 2006;28(5):307–14.

    Article  PubMed  Google Scholar 

  20. Théaudin M, Romero K, and Feinstein A. “In multiple sclerosis anxiety, not depression, is related to gender.” Multiple Sclerosis Journal. 2016;22(2):239–244.

    Google Scholar 

  21. Nagels G, Geentjens L, Kos D, Vleugels L, D’hooghe MB, Van Asch P, et al. Paced visual serial addition test in multiple sclerosis. Clin Neurol Neurosurg. 2005;107:218–22.

    Article  PubMed  Google Scholar 

  22. Da Silva AM, Vilhena E, Lopes A, Santos E, Gonçalves MA, Pinto C, et al. Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease. J Neurol Sci. 2011;306(1–2):66–70.

    Article  PubMed  Google Scholar 

  23. Brown RF, Valpiani EM, Tennant CC, Dunn SM, Sharrock M, Hodgkinson S, et al. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother. 2009;82(Pt 1):41–56.

    Article  CAS  PubMed  Google Scholar 

  24. Jones K, Ford D, Jones P, John A, Middleton R, Lockhart-Jones H, et al. A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS register. PLoS One. 2012;7(7):1–10.

    Article  Google Scholar 

  25. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler. 2007;13(1):67–72.

    Article  CAS  PubMed  Google Scholar 

  26. Poder K, Ghatavi K, Fisk JD, Campbell TL, Kisely S, Sarty I, et al. Social anxiety in a multiple sclerosis clinic population. Mult Scler. 2008;15(3):393–8.

    Article  PubMed  Google Scholar 

  27. Feinstein A, O’Connor P, Gray T, Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler. 1999;5(5):323–6.

    Article  CAS  PubMed  Google Scholar 

  28. Quesnel S, Feinstein A. Multiple sclerosis and alcohol: a study of problem drinking. Mult Scler. 2004;10(2):197–201.

    Article  PubMed  Google Scholar 

  29. Pozzilli C, Tomassini V, Marinelli F, Paolillo A, Gasperini C, Bastianello S. “Gender gap” in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol. 2003;10(1):95–7.

    Article  CAS  PubMed  Google Scholar 

  30. Koenig K, Lowe M, Lin J, Sakaie K, Stone L, Bermel R, et al. Sex differences in resting-state functional connectivity in multiple sclerosis. AJNR Am J Neuroradiol. 2013;34(12):2304–11.

    Article  CAS  PubMed  Google Scholar 

  31. Fraser C, Polito S. A comparative study of self‐efficacy in men and women with multiple sclerosis. J Neurosci Nurs. 2007;39(2):102–6.

    Article  PubMed  Google Scholar 

  32. Jensen MP, Smith AE, Bombardier CH, Yorkston KM, Miró J, Molton IR. Social support, depression, and physical disability: age and diagnostic group effects. Disabil Health J. 2014;7(2):164–72.

    Article  PubMed  Google Scholar 

  33. Schiffer RB, Wineman N, Weitkamp L. Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatry. 1986;143:94–5.

    Article  CAS  PubMed  Google Scholar 

  34. Schiffer RB, Weitkamp LR, Wineman NM, Guttormsen S. Multiple sclerosis and affective disorder: family history, sex, and HLA-DR antigens. Arch Neurol. 1988;45(12):1345–8.

    Article  CAS  PubMed  Google Scholar 

  35. Feinstein A, Feinstein K, Gray T, O’Connor P. Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol. 1997;54(9):1116–21.

    Article  CAS  PubMed  Google Scholar 

  36. Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med. 1985;312(23):1480–2.

    Article  CAS  PubMed  Google Scholar 

  37. Seliger GM, Hornstein A, Flax J, Herbert J, Schroeder K. Fluoxetine improves emotional incontinence. Brain Inj. 1992;6(3):267–70.

    Article  CAS  PubMed  Google Scholar 

  38. Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol. 2006;59(5):780–7.

    Article  CAS  PubMed  Google Scholar 

  39. Fishman I, Benedict RHB, Bakshi R, Priore R, Weinstock-Guttman B. Construct validity and frequency of euphoria sclerotica in multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2004;16(3):350–6.

    Article  PubMed  Google Scholar 

  40. Rabins PV, Brooks BR, O’donnell P, Pearlson GD, Moberg P, Jubelt B, et al. Structural brain correlates of emotional disorder in multiple sclerosis. Brain. 1986;109(4):585–97.

    Article  PubMed  Google Scholar 

  41. Miller A, Dishon S. Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Qual Life Res. 2006;15(2):259–71.

    Article  PubMed  Google Scholar 

  42. Casetta I, Riise T, Wamme Nortvedt M, Economou NT, De Gennaro R, Fazio P, et al. Gender differences in health-related quality of life in multiple sclerosis. Mult Scler. 2009;15(11):1339–46.

    Article  PubMed  Google Scholar 

  43. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klösch G, Kollegger H, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004;110(1):6–13.

    Article  CAS  PubMed  Google Scholar 

  44. Chiaravalloti ND, Genova HM, DeLuca J. Cognitive rehabilitation in multiple sclerosis: the role of plasticity. Front Neurol. 2015;6:67.

    Article  PubMed  PubMed Central  Google Scholar 

  45. De Giglio L, De Luca F, Prosperini L, Borriello G, Bianchi V, Pantano P, et al. A low-cost cognitive rehabilitation with a commercial video game improves sustained attention and executive functions in multiple sclerosis a pilot study. Neurorehabil Neural Repair. 2015;29(5):453–61.

    Article  PubMed  Google Scholar 

  46. Beatty WW, Aupperle RL. Sex differences in cognitive impairment in multiple sclerosis. Clin Neuropsychol. 2002;16(4):472–80.

    Article  PubMed  Google Scholar 

  47. Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ, et al. Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler. 2012;18(2):164–73.

    Article  PubMed  Google Scholar 

  48. Schoonheim MM, Popescu V, Lopes FCR, Wiebenga OT, Vrenken H, Douw L, et al. Subcortical atrophy and cognition Sex effects in multiple sclerosis. Neurology. 2012;79(17):1754–1761.

    Google Scholar 

  49. Schoonheim MM, Vigeveno RM, Lopes FCR, Pouwels PJW, Polman CH, Barkhof F, et al. Sex-specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline. Hum Brain Mapp. 2014;35(5):2348–2358.

    Google Scholar 

  50. Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R, et al. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol. 2004;251(10):1208–14.

    Article  PubMed  Google Scholar 

  51. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343(13):938–52.

    Article  CAS  PubMed  Google Scholar 

  52. Whitacre CC, Reingold SC, O’Looney PA. A gender gap in autoimmunity. Science. 1999;283(5406):1277.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sunnybrook Health Sciences Centre, Department of Psychiatry, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada

    Anthony Feinstein PhD, MD

  2. University of Toronto, Toronto, ON, Canada

    Anthony Feinstein PhD, MD & Bennis Pavisian BAH

Authors
  1. Anthony Feinstein PhD, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bennis Pavisian BAH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony Feinstein PhD, MD .

Editor information

Editors and Affiliations

  1. Partners MS Center, Brigham and Women’s Hospital Harvard Medical School, Boston, Massachusetts, USA

    Maria K. Houtchens

  2. MS Clinic UBC Medical Genetics, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada

    A. Dessa Sadovnick

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Wien

About this chapter

Cite this chapter

Feinstein, A., Pavisian, B. (2017). Multiple Sclerosis, Gender, and Disorders of Behavior. In: Houtchens, M., Sadovnick, A. (eds) Health Issues in Women with Multiple Sclerosis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-4858-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-4858-7_9

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-4856-3

  • Online ISBN: 978-3-7091-4858-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation